219 related articles for article (PubMed ID: 15675087)
1. Institutional review boards and clinical trials registry.
Maloney DM
Hum Res Rep; 2004 Nov; 19(11):3. PubMed ID: 15675087
[No Abstract] [Full Text] [Related]
2. New European clinical trial regulations are "unacceptable" to industry.
Davidson S
Nat Biotechnol; 1998 Feb; 16(2):127. PubMed ID: 9487504
[No Abstract] [Full Text] [Related]
3. Institutional review boards (IRBs) would have an increased role in international research.
Maloney DM
Hum Res Rep; 2002 Oct; 17(10):9. PubMed ID: 12731498
[No Abstract] [Full Text] [Related]
4. How institutional review boards (IRBs) can handle adverse event reports.
Maloney DM
Hum Res Rep; 2006 Jan; 21(1):1-3. PubMed ID: 16789305
[No Abstract] [Full Text] [Related]
5. Registration of clinical trials--voluntary or mandatory?
Steinbrook R
N Engl J Med; 2004 Oct; 351(18):1820-2. PubMed ID: 15509812
[No Abstract] [Full Text] [Related]
6. Clinical trials registries: towards improved access to therapeutic data.
Prescrire Int; 2008 Dec; 17(98):256-9. PubMed ID: 19425275
[TBL] [Abstract][Full Text] [Related]
7. The old file-drawer problem.
Kennedy D
Science; 2004 Jul; 305(5683):451. PubMed ID: 15273363
[No Abstract] [Full Text] [Related]
8. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry.
Dorfman HL; Reig LP
Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876
[No Abstract] [Full Text] [Related]
9. Public health. Clinical trials results databases: unanswered questions.
Fisher CB
Science; 2006 Jan; 311(5758):180-1. PubMed ID: 16410509
[No Abstract] [Full Text] [Related]
10. Research involving children: regulations, review boards and reform.
Gandhi R
J Health Care Law Policy; 2005; 8(2):264-330. PubMed ID: 16471026
[No Abstract] [Full Text] [Related]
11. Continued concern: human subject protection, the institutional review board, and continuing review.
Hoffman S
Tenn Law Rev; 2001; 68(4):725-70. PubMed ID: 16189912
[No Abstract] [Full Text] [Related]
12. Drug research. Legislators propose a registry to track clinical trials from start to finish.
Couzin J
Science; 2004 Sep; 305(5691):1695. PubMed ID: 15375239
[No Abstract] [Full Text] [Related]
13. Regulatory and ethical considerations for linking clinical and administrative databases.
Dokholyan RS; Muhlbaier LH; Falletta JM; Jacobs JP; Shahian D; Haan CK; Peterson ED
Am Heart J; 2009 Jun; 157(6):971-82. PubMed ID: 19464406
[TBL] [Abstract][Full Text] [Related]
14. Calls for full disclosure of clinical trials.
Frantz S
Nat Rev Drug Discov; 2004 Aug; 3(8):635-6. PubMed ID: 15317144
[No Abstract] [Full Text] [Related]
15. Clinical trials: a medical Catch-22. Researchers, institution boards must take appropriate steps to protect participants.
Serbaroli F
Mod Healthc; 2002 Oct; 32(41):23. PubMed ID: 12415995
[No Abstract] [Full Text] [Related]
16. New federal guidance adds duties for institutional review boards (IRBs).
Maloney DM
Hum Res Rep; 2005 Nov; 20(11):1-2. PubMed ID: 16358479
[No Abstract] [Full Text] [Related]
17. Institutional review boards (IRBs) and working with adverse event reports.
Maloney DM
Hum Res Rep; 2005 Dec; 20(12):1-3. PubMed ID: 16607708
[No Abstract] [Full Text] [Related]
18. Public registration of clinical trials.
Steinbrook R
N Engl J Med; 2004 Jul; 351(4):315-7. PubMed ID: 15269307
[No Abstract] [Full Text] [Related]
19. Trials and tribulations: new pressure on drug companies to reveal all about their clinical tests.
Economist; 2004 Jun; 371(8380):62-3. PubMed ID: 15457617
[No Abstract] [Full Text] [Related]
20. Drugmakers prefer silence on test data; firms violate US law by not registering trials.
Vedantam S
Washington Post; 2004 Jul; ():A1, A4. PubMed ID: 15290815
[No Abstract] [Full Text] [Related]
[Next] [New Search]
